Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging

Metabolites can be an important read-out of disease. The identification and validation of biomarkers in the cancer metabolome that can stratify high-risk patients is one of the main current research aspects. Mass spectrometry has become the technique of choice for metabolomics studies, and mass spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lou, Sha, Balluff, Benjamin, Cleven, Arjen H. G., Bovée, Judith V. M. G., McDonnell, Liam A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227002/
https://www.ncbi.nlm.nih.gov/pubmed/27873216
http://dx.doi.org/10.1007/s13361-016-1544-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227002/
https://www.ncbi.nlm.nih.gov/pubmed/27873216
http://dx.doi.org/10.1007/s13361-016-1544-4

Ejemplares similares